Pfizer is a value and high-yield compared to its peers and it it outperforming expectations in 2023; The pipeline is robust.
© 2023 The Abundance Pub. All rights reserved.
All trademarks and service marks are the property of their respective owners. This site is not intended to provide, and does not constitute, medical, health, legal, investment, financial or other professional advice.